Gabapentin Tablet
Product Images NDC 76420-497

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 76420-497). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-800mg (Gabapentin 800mg)

This is a list of Gabapentin tablets with different NDC numbers, quantities, and packaging information. The tablets have a strength of 800 mg and are manufactured by ScieGen Pharmaceuticals, Inc. The labels include a caution about the federal law prohibiting dispensing without a prescription and a recommendation to keep them out of reach of children and store them at 20.25C (68-77F). Some of the tablets have been repackaged by Enovachem.*

FDA Label Image

Figure 1 (Image 01)

FDA Label Image

Figure 2 (Image 02)

This appears to be a graph or chart showing pain scores over a period of several weeks. The x-axis is labeled "Weeks" and the y-axis is labeled "Mean Pain Score." It seems that there were three different dosage regimens being tested: a placebo, gabapentin at 1800mg/day, and gabapentin at 2400mg/day. The graph suggests that the higher dosage of gabapentin was associated with lower pain scores as compared to the placebo or lower dose of gabapentin.*

FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Image-04 (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.